CRP and lung carcinoma: The data of two large Danish population studies indicate that simultaneously elevated levels of CRP, fibrinogen and leukocyte count are associated with a two- to fourfold risk of major comorbidities (e.g. myocardial infarction, lung cancer) in COPD [15].